Lifecore Biomedical Inc
Închisă
SectorConsumator defensiv
4.08 -0.24
Rezumat
Modificarea prețului
24h
Minim
4.04
Maxim
4.16
Venit | 9.8M -6.2M |
|---|---|
Vânzări | 11M 34M |
Marjă de profit | -18.017 |
Angajați | 382 |
Următoarele câștiguri | 10 dec. 2026 |
|---|
Capitalizare de piață | -20M 140M |
|---|---|
Deschiderea anterioară | 4.32 |
Închiderea anterioară | 4.08 |
Sentimentul știrilor
By Acuity
50%
50%
56 / 130 Clasament în Consumer defensive
Lifecore Biomedical Inc Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
Lifecore Biomedical Inc Așteptări
Sentiment
By Acuity
56 / 130 Clasament în Consumator defensiv
Sentimentul știrilor
Neutral
Volatilitate
Sub medie
Volumul știrilor (RCV)
Peste medie
Date financiare
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$
Despre Lifecore Biomedical Inc
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.